Related Experiment Video
Updated: Jun 15, 2025

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
Data Quality in Medical Real-World Data - An Oncological Use Case
Julia Gehrmann1, Oya Beyan1,2
1Institute for Biomedical Informatics Cologne, Germany.
Studies in Health Technology and Informatics
|August 23, 2024
Summary
Data quality issues like missing information and class imbalance hinder real-world data use in medical research. This study highlights these common deficiencies in cancer datasets to improve data-driven healthcare.
Area of Science:
- Medical Informatics
- Oncology
- Data Science
Background:
- Real-world data (RWD) is crucial for data-driven medical research.
- Data quality deficiencies significantly limit the utility of RWD.
- Common issues include missing data, class imbalances, and timeliness problems.
Purpose of the Study:
- To identify and discuss common data quality deficiencies in real-world medical datasets.
- To analyze these deficiencies within an oncological use case.
- To improve the applicability of RWD in medical research.
Main Methods:
- Compiled a multi-departmental real-world dataset of 13861 cancer cases from University Hospital Cologne.
- Examined data quality throughout the data integration process.
- Focused on identifying missing data, class imbalances, and timeliness issues.
Main Results:
- Identified significant data quality deficiencies in the real-world cancer dataset.
- Observed issues such as missing patient information and imbalanced representation of cancer classes.
- Timeliness of data recording also presented challenges.
Conclusions:
- Data quality deficiencies are prevalent in real-world medical datasets, particularly in oncology.
- Addressing these issues is essential for reliable data-driven medical research.
- Improving data quality enhances the value of RWD for clinical insights and healthcare advancements.
Related Concept Videos
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

